 
								Hycult Biotech/C3b/iC3b/C3c,小鼠,单克隆抗体2/11,免疫分析抗体/HM1065-IA/0.5mg
								
										商品编号:
										HM1065-IA
									
									
										品牌:
										hycultbiotech
									
									
								
										市场价:
										¥26232.00
									
									
										美元价:
										15739.20
									
								
										产品分类:
										标签抗体
									
									
										公司分类:
										Tag_antibody
									
								
										联系Q Q:
										3392242852
									
									
										电话号码:
										4000-520-616
									
								
										电子邮箱:
										info@ebiomall.com
									
									商品介绍
						Description:C3b/iC3b/C3c,Mouse,mAb2/11,immunoassayantibody
Themonocolonalantibody2/11recognizesactivatedfragmentsofthemousecomplementproteinC3.Thecomplementsystemisanimportantpartofthehumoralresponseininnateimmunity,consistingofthreedifferentpathways.Thethirdcomplementcomponent,C3,iscentraltotheclassical,alternativeandlectinpathwaysofcomplementactivation.Activationproductsofthecomplementcascadecontainneo-epitopesthatarenotpresentintheindividualnativecomponents.
ThesynthesisofC3istissue-specificandismodulatedinresponsetoavarietyofstimulatoryagents.C3isthemostabundantproteinofthecomplementsystemwithserumproteinlevelsofabout1.3mg/ml.AninheriteddeficiencyofC3predisposesthepersontofrequentassaultsofbacterialinfections.Inulcerativecolitis,andidiopathicchronicinflammatoryboweldisease,thedepositionofC3inthediseasedmucosahasbeenreported.
ProteolysisbycertainenzymesresultsinthecleavageofC3intoC3aandC3b.C3bbecomesattachedtoimmunecomplexesandisfurthercleavedintoiC3b,C3c,C3dgandC3f.Themonoclonalantibody2/11isspecificforcleavedC3fragmentsC3b,iC3b,andC3c,andforactivatedC3.Therefore,positivereactivityintissuesisassociatedwithactivationofhecomplementcascadeandC3cleavage.IncaseofanacuteinflammatoryreactionlotsofC3areprocessedintotheproductsrecognizedby2/11andisassuchusefulasMarkerforinflammatoryreaction.Inchronicinflammatoryconditionsminimalreactivitywith2/11mayobserved.InsuchcasesprimarilytheC3dgproductresidesattheplaceofinflammation(C3cbeingcleared)whichisnotrecognizedbyantibody2/11.Thechronicprocessing/activationofC3istakingplaceatalowerlevel,whichwouldreducedetectionoftheC3fragmentsC3b,iC3b,andC3c.
NexttodetectionofC3fragmentsC3b,iC3b,andC3c,themonoclonalantibody2/11inhibitsthehemolyticactivityofmousecomplementinadose-dependentmanner.
ThesynthesisofC3istissue-specificandismodulatedinresponsetoavarietyofstimulatoryagents.C3isthemostabundantproteinofthecomplementsystemwithserumproteinlevelsofabout1.3mg/ml.AninheriteddeficiencyofC3predisposesthepersontofrequentassaultsofbacterialinfections.Inulcerativecolitis,andidiopathicchronicinflammatoryboweldisease,thedepositionofC3inthediseasedmucosahasbeenreported.
ProteolysisbycertainenzymesresultsinthecleavageofC3intoC3aandC3b.C3bbecomesattachedtoimmunecomplexesandisfurthercleavedintoiC3b,C3c,C3dgandC3f.Themonoclonalantibody2/11isspecificforcleavedC3fragmentsC3b,iC3b,andC3c,andforactivatedC3.Therefore,positivereactivityintissuesisassociatedwithactivationofhecomplementcascadeandC3cleavage.IncaseofanacuteinflammatoryreactionlotsofC3areprocessedintotheproductsrecognizedby2/11andisassuchusefulasMarkerforinflammatoryreaction.Inchronicinflammatoryconditionsminimalreactivitywith2/11mayobserved.InsuchcasesprimarilytheC3dgproductresidesattheplaceofinflammation(C3cbeingcleared)whichisnotrecognizedbyantibody2/11.Thechronicprocessing/activationofC3istakingplaceatalowerlevel,whichwouldreducedetectionoftheC3fragmentsC3b,iC3b,andC3c.
NexttodetectionofC3fragmentsC3b,iC3b,andC3c,themonoclonalantibody2/11inhibitsthehemolyticactivityofmousecomplementinadose-dependentmanner.
Specifications:
| Catalognumber | HM1065-IA | 
|---|---|
| Producttype | Monoclonalantibodies | 
| Quantity | 0.5mg | 
| Formulation | 0.5mgof0.2μmfilteredproteinGpurifiedantibodysolutioninPBSwithaconcentrationofatleast0.5mg/ml(exactconcentrationisindicatedonthelabel). | 
| Application | Flowcytometry,Frozensections,Functionalstudies,Immunoassays,Immunofluorescence,Westernblot | 
| ApplicationNotes | F:Fixationofsectionsinacetonefor5‘,pretreatmentwith3%hydrogenperoxideinmethanolatRTtoquenchendogenousperoxidases.Asnegativecontrol,sectionsfromC3-deficientmicewereused.(Ref.1) FC:Mousesplenocyteswereincubatedwithautologous,freshlydrawnmouseserumtofixtheC3fragmentsbeforestaining.AsnegativecontrolsplenocytesofC3deficientmicewasused.Antibody2/11stainstheneoantigenicsiteontheC3activationfragments.(Ref.1) FS:Antibody2/11inhibitshemolysisinadose-dependentmanner.(Ref.1) W:Anon-reducedsampletreatmentandSDS-PAGEwasused.Thebandsizeis150kDa(Ref.1). IA:Supernatantofantibody2/11wasincubatedonanti-ratIgGFccoatedplates.Afterincubationwithsample,HRP-conjugatedpolyclonalgoatanti-mouseC3wasusedfordetection.(Ref.1) | 
| Use | Dilutionstobeuseddependondetectionsystemapplied.Itisrecommendedthatuserstestthereagentanddeterminetheirownoptimaldilutions.Thetypicalstartingworkingdilutionis1:50. | 
| Immunogen | MouseC3 | 
| Isotype | RatIgG1 | 
| Species | Mouse | 
| PositiveControl | Mousesplenocytespreincubatedwithserumfromthesameanimal. | 
| NegativeControl | C3-deficientmousecells. | 
| References | 1.Mastellos,Detal;NovelmonoclonalantibodiesagainstmouseC3interferingwithcomplementactivation:descriptionoffinespecificityandapplicationstovariousimmunoassays.MolImmunol2004,40:1213 2.Markiewski,Metal;C3aandC3bactivationproductsofthethirdcomponentofcomplement(C3)arecriticalfornormalliverrecoveryaftertoxicinjury.JImmunol2004,173:747 3.Markiewski,Metal;Modulationoftheantitumorimmuneresponsebycomplement.NatImmunol2008,9:1225 | 
| StorageandstABIlity | Productshouldbestoredat4 °C.Underrecommendedstorageconditions,productisstableforoneyear. | 
| Precautions | Forresearchuseonly.Notforuseinoronhumansoranimalsorfordiagnostics.Itistheresponsibilityoftheusertocomplywithalllocal/stateandFederalrulesintheuseofthisproduct.HycultBiotechisnotresponsIBLeforanypatentinfringementsthatmightresultwiththeuseoforderivationofthisproduct. | 
| Disease | Infectiousdiseases,Nephrology | 
品牌介绍
						荷兰HyCult Biotechnology(HBT)位于荷兰乌登,从1994开始制造检测抗体和蛋白质,主要侧重与病理学诊断有关的全套产品研发,既有纯化的重组蛋白和多肽,也有单抗和多抗,是世界一流的先天免疫领域的研究试剂制造商。
					联络我们
	

 
		
